|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1400 Crystal Drive |
Address2 | Suite 300 |
| City | Arlington |
State | VA |
Zip Code | 22202 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 46803-12
|
||||||||
|
6. House ID# 343580000
|
||||||||
| TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Dorothy Farrell |
Date | 10/16/2019 2:27:32 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER
Signed onto letter led by friends of AHRQ as House and Senate begin Fiscal 2020 conference negotiations amongst appropriators urging them to support a final funding level equal to, or above the House-passed level of $358.2 million for AHRQ.
HOUSE/SENATE - H.R. 2328 Reauthorizing and Extending Americas Community Health Act
Signed coalition letter led by NIDDK to House and Senate leaders (Reps. Nancy Pelosi and Kevin McCarthy and Sens. Mitch McConnell and Charles Schumer) urging reauthorization of the Special Diabetes Program through H.R. 2328 Reauthorizing and Extending America's Community Health Act or the "REACH Act."
HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER
Signed onto letter led by the Ad Hoc Group Steering Committee for Medical Research urging House and Senate appropriators to ensure quick enactment of Labor-HHS-Education appropriations bill that provides robust, sustained funding for medical research. This letter has an emphasis on NIH funding.
SENATE - Funding Bill FY20
Signed onto Giffords Coalition letter urging Senate leadership to include the House passed Fiscal Year 2020 Labor, Health and Human Services, Education, and Related Agencies funding bill, which includes $50 million for the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to conduct research into gun violence.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dorothy |
Farrell |
|
|
|
Jasey |
Cardenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
HOUSE - H.R. 987/Discussion of Pharmacy Education
Visiting Office of office Rep. Lucy McBath in response to an amendment offered by the representative to H.R. 987. The amendment calls for DHHS and DoEd to do all needed outreach to make sure faculty and students at colleges of pharmacy have all necessary materials about generic drugs and biosimilar biological products. AACP welcomes the representatives support for pharmacists and pharmacy students.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jasey |
Cardenas |
|
|
|
Dorothy |
Farrell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
SENATE - DREAM ACT (S. 874/H.R. 6)
Signed onto Health Professionals Coalition letter in support of the DREAM Act (S. 874/H.R. 6). This letter urges the Senate to adopt H.R. 6 the Dream and Promise Act recently passed by the House or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
SENATE - Letter to Secretary Azar of Department of HHS
Singed onto letter led by the Coalition on Fetal Tissue Research expressing concerns regarding two NIH guide notices Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding Proposed Human Fetal Tissue Research. The letter sent to Secretary Azar expresses concerns that both the policy underlying these notices (i.e., the requirement that human fetal tissue research proposals be subject to an additional layer of review) and the specific requirements of these notices will create substantial barriers to important biomedical research, jeopardize the integrity of the peer-review process, and create an unnecessarily cumbersome and bureaucratic process for reviewing crucial research.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dorothy |
Farrell |
|
|
|
Jasey |
Cardenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Status of pharmacists as health care providers for Medicare/Medicaid services
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dorothy |
Farrell |
|
|
|
Jasey |
Cardenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
HOUSE - H.R. 1236 the Extreme Risk Protection Order Act
Contacted by Representative Carbajal to sign on in support of their introduction of H.R. 1236 the Extreme Risk Protection Order Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jasey |
Cardenas |
|
|
|
Dorothy |
Farrell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
FIR |
BUD |
EDU |
HCR |
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |